@MedscapeNurses profile picture
Medscape Nurses @MedscapeNurses

Medscape Nurses helps you stay current with breaking medical news; quickly look up drugs, diseases, and procedures; and complete free CE activities.

Joined March 2009
  • Tweets 25,280
  • Following 58
  • Followers 30,315
5,753 Photos and videos
🧠 Real questions. Real answers. Real impact. 💥 Join a high-impact forum covering HR , HER2 , and triple-negative breast cancer—designed for clinicians who want practical, usable insights. 🎙️ Ask experts, challenge thinking, and leave with strategies you can apply immediately. 📌 mdsc.pe/4cOgVkG #PBCClive26
55
What’s new in mCRC care? 🧬 Join our 15-min live stream with Dr. Pietrantonio & Dr. Oberstein to break down new data and regimens to overcome EGFR inhibitor resistance. 📅 June 19th ⏰ 3:30pm ET 🔗 mdsc.pe/4azXhr3 #Oncology #CME
35
How are the latest target therapies shifting the way you approach the early stages of IDH-mutant glioma management? Come explore the new era of glioma management with us, and dive into expert strategies for timing therapies just right and tailoring your approach to each unique patient. Read here: mdsc.pe/4uF9m6u
30
Are your IgA Nephropathy patients missing early signs? Dr. Shikha Wadhwani and patient John Marsala discuss the critical reality of early diagnosis, routine urine checks, and navigating a lifelong kidney disease. Watch the full discussion ➡️ mdsc.pe/3QhuvEI #IgANephropathy #Nephrology #CME
0:30
94
Could lipid-lowering therapies also impact dementia and kidney health? We dive into the latest data on CETP inhibitors and what it means for the future of comprehensive patient care. Watch the full discussion ➡️ x.com/i/broadcasts/1dKrPEXBy… #Cardiology #CME
0:08
42
nuStarting in 1 HOUR ➡️ youtube.com/watch?v=S0QxMEYZ… Don't miss our live stream with Dr. Alicia Morgans! Get up to speed on the latest 2026 mHSPC data and join the real-time Q&A on treatment intensification with ARPIs. See you there! #mHSPC #ProstateCancer #Oncology
35
How have newer targeted therapies shifted how you use radiation in daily glioma management? Explore the foundational role of radiation oncology today and get actionable tips to optimize treatment timing and outcomes. Read here:: mdsc.pe/49W4AsS
Microscopic image of a red, spherical cancer cell with irregular surface texture, surrounded by thin, hair-like structures. The background is dark, highlighting the cell's vivid color and detail.

ALT Microscopic image of a red, spherical cancer cell with irregular surface texture, surrounded by thin, hair-like structures. The background is dark, highlighting the cell's vivid color and detail.
1
60
Still relying solely on standard anti-infectives for recurrent C. diff? Discover how balancing immediate treatment with targeted microbiome repair addresses the root cause and breaks the cycle. Watch the full discussion ➡️ mdsc.pe/4vfyIYm #Gastroenterology #CDiff #CME
0:30
60
Starting in 1 HOUR ➡️ mdsc.pe/4dDTj1w MASH screening is changing. Join our live expert exchange with Dr. Alkhouri and Dr. Kumar to get a clear look at noninvasive testing and risk stratification strategies. 📉 #Gastroenterology #PrimaryCare #CME
1
45
As automated insulin delivery (AID) and pump options expand, navigating routine care can bring clinical uncertainty. Join our expert panel to clear up common practical questions and gain the insights needed to confidently integrate pump therapy into your T2D management strategies. 🗓️ June 18th ⏰ 5:00pm ET 🔗 mdsc.pe/3ROVqYZ #Diabetes #T2D #CME
1
1
40
LIVE TOMORROW ➡️ The Blueprint for Modern mHSPC Care. Bring your questions as Dr. Alicia Morgans breaks down the key abstracts in mHSPC presented so far in 2026, with a focus on treatment intensification with androgen receptor pathway inhibitors (ARPIs). 📅 June 12th ⏰ 10:30am EST 🔗 youtube.com/watch?v=S0QxMEYZ… #mHSPC #Oncology #CME
31
LIVE TOMORROW: NITs Demystified. ➡️ mdsc.pe/4dDTj1w Tune in for a concise, high-impact session on understanding and implementing the noninvasive toolkit for metabolic dysfunction–associated steatohepatitis with Dr. Alkhouri and Dr. Kumar. See you there! 🗓️ Thursday, June 11th ⏰ 12:00pm ET #MASHMasters #Gastroenterology #MedEd
33
Monotherapy is rapidly being relegated to the past. Learn why early combination protocols are non-negotiable to delay progression to castration resistance and maximize patient survival. Catch up on the latest data ➡️ mdsc.pe/4wRNM0d #Oncology #MedEd #CME
0:27
31
Are your T2D patients struggling with tedious carb counting on smart pumps? Learn how to streamline mealtime settings, simplify user engagement, and drastically reduce glycemic variability with this expert tip. Full episode here ➡️ mdsc.pe/4vjbhh5 #T2D #CME #Endocrinology
0:32
37
Starting in 1 HOUR ➡️ mdsc.pe/4wOudWz The MASH landscape is changing fast. Join our live expert exchange with Dr. Alkhouri and Dr. Allen to walk through the pathway from screening to diagnosis. 📉 #Gastroenterology #PrimaryCare #CME
30
Don't let partial treatment responses leave your patients stranded. Learn how to leverage a well-tolerated first-line platform and build an effective, combined strategy for residual symptoms. Catch up on Episode 1 ➡️ mdsc.pe/4dLwjh6 #Depression #Psychiatry #CME
0:24
42
SAVE THE DATE 🗓️ Got 15 mins? Join Dr. Filippo Pietrantonio & Dr. Paul Oberstein to tackle EGFR inhibitor resistance and data for novel regimens to overcome it. 📅 June 19th ⏰ 3:30pm ET 🔗 mdsc.pe/4azXhr3 #Oncology #CME
53
Still struggling to hit LDL targets with statins alone? Explore how combination therapies involving CETP inhibitors could reduce LDL by up to 50%. Watch the full discussion ➡️ x.com/i/broadcasts/1dKrPEXBy… #HeartHealth #CME
0:08
37
LIVE TOMORROW: Enhance your approach to MASH management. ➡️ mdsc.pe/4wOudWz Tune in for this concise, high-impact session on implementing the newest care pathways with Dr. Alkhouri and Dr. Allen. Don't miss out! 🗓️ Wednesday, June 10th ⏰ 12:00pm ET #MASHMasters #Hepatology #MedEd
32
With lung cancer research moving faster than ever, what is your biggest challenge when trying to keep up with new data for ALK-positive and small-cell lung cancers? Join us to explore breaking developments and emerging science in ALK-positive NSCLC and ES-SCLC, and discover practical ways to bring these cutting-edge advancements straight to your clinic. Read here: mdsc.pe/4u3Umhw
A digital illustration depicting blood components: red blood cells, purple antibodies, and a large blue enzyme structure against a pink background.

ALT A digital illustration depicting blood components: red blood cells, purple antibodies, and a large blue enzyme structure against a pink background.
43
Load more